References
- Tfelt-Hansen P, Saxena PR, Ferrari MD. Ergot alkaloids. In: de Wolf FA, ed. Handbook of Clinical Neurology, Vol. 21, Intoxications of the nervous system. Part II. Amsterdam, Elsevier, 1995:61–78
- Tfelt-Hansen P, Saxena PR. Ergot alkaloids in the acute treatment of migraine. In: Olesen J, Tfelt-Hansen P, Welch KMA, eds. The Headaches, 2nd edn. Philadelphia: Lippincott Williams & Wilkins 2000:399–409
- Graham JR, Wolff HG. Mechanism of migraine headache and action of ergotamine tartrate. Arch Neurol Psychiatr 1938;39:737–63
- Buzzi, MG, Moskowitz MA. Evidence for 5-HT1B/1D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine. Cephalalgia 1991;11: 165–8
- Buzzi MG, Moskowitz MA, Peroutka SJ, Byun B. Further characterization of the putative 5HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura mater. Br J Pharmacol 1991;103:1421–8
- Hoskin KL, Kaube H, Goadsby PG. Central activation of the trigeminovascular pathway in the cat is inhibited by dihydroergotamine. A c-Fos and electrophysiological study. Brain 1996;119:249–56
- Peroutka SJ. Drugs effective in the therapy of migraine. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG eds. Goodman and Gilman’s: The Pharmacological Basis of Therapeutics, 9th edn. New York: McGraw-Hill, 1996:487–502
- Tfelt-Hansen P, Saxena PR, Dahlof C, et al. Ergotamine in the acute treatment of migraine – European Consensus. Brain 2000;123:9–18
- Tfelt-Hansen P. The effect of ergotamine on the arterial system in man. Acta Pharmacol Toxicol 1986; 59 (Suppl3):1–30
- Silberstein SD, Hargreaves RJ. The history and pharmacology of ergotamine and dihydroergotamine. In: Diener HC ed. Drug Treatment of Migraine and Other Headaches. Monographs in Clinical Neuroscience. Basel: Karger, 2000: 52–65
- Swedish Medical Products Agency. Monograph on sumatriptan suppositories [on line]. Available from: http://mpa.se/lakemedel/nn_lakeindex.html [Accessed July 5, 2001]. Ref. 23: Drugs 2000;60: 1259–87
- Callaham M, Raskin N. A controlled study of dihydroergotamine in the treatment of acute migraine headache. Headache 1986;26:168–71
- Scott AK. Dihydroergotamine: a review of its use in the treatment of migraine and other headaches. Clin Neuropharmacol 1992;15:289–92
- Gallagher RM. Dihydroergotamine Working Group. Acute treatment of migraine with dihydroergotamine nasal spray. Arch Neurol 1996;53:1285–91
- Touchon J, Bertin L, Pilgrim AJ, Ashford E, Bès A. A comparison of subcutaneous sumatriptan and dihydroergotamine in the acute treatment of migraine. Neurology 1996;47:361–5
- Dahlof C. Sumatriptan nasal spray in the acute treatment of migraine: a review of clinical studies. Cephalalgia 1999; 19:769–78
- Winner P, Ricalde O, Le Force B, et al. A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine. Arch Neurol 1996;53:180–4
- Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: appropriate use of ergotamine tartrate and dihydroergotamine in the treatment of migraine and status migrainosus (summary statement). Neurology 1995;45:585–7
- Silberstein SD, Young WB. Safety and efficacy of ergotamine tartrate and dihydroergotamine in the treatment of migraine and status migrainosus. Neurology 1995; 45:577–84
- Galer BS, Lipton RB, Solomon S, et al. Myocardial ischemia related to ergot alkaloids: a case report and literature review. Headache 1991;31: 446–50
- de Groot ANJA, van Dongen PWJ, van Roosmalen J, Eskes TKAB. Ergotamine-induced fetal stress: review of side effects of ergot alkaloids during pregnancy. Eur J Obstet Gynecol Reprod Biol 1993;51:71–7
- Raymond GV. Teratogen update: ergot and ergotamine. Teratology 1995;51:344–7
- Tfelt-Hansen P, De Vries P, Saxena PR. Triptans in migraine: a comparative review of their pharmacology, pharmacokinetics and efficacy. Drugs, in press
- Tfelt-Hansen P. Antiemetics, prokinetics, neuroleptic and miscellaneous drugs in the acute treatment of migraine. In: Olesen J, Tfelt-Hansen P, Welch KMA, eds. The Headaches, 2nd edn. Philadelphia: Lippincott Williams & Wilkins 2000:445–52
- Raskin NH. Headache, 2nd edn. New York: Churchill Livingstone, 1988 Ref. 11: Swedish Medical Products Agency. Monograph on sumatriptan suppositories [on line]. Available from: mpa.se/lakemedel/nn_lakeindex [Accessed 2001 July 5]. Ref. 23: Drugs 2000; 60: 1259–1287.